Condition: Erythematotelangiectatic Rosacea · Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine
The efficacy and safety of anti-inflammation treatment (Hirudoid introduction followed by yellow light therapy) combined with tofacitinib and doxycycline in Chinese adult patients with mild to moderate erythematous telangiectatic rosacea: A prospective parallel controlled single-blind cohort study
This description comes directly from the study's public registry record.
Liu · 0579-89979999 · 2197055@zju.edu.cn
Always discuss trial participation with your own doctor first.
| The Fourth Affiliated Hospital of Zhejiang University School of Medicine | Yiwu, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07343635